What are the obligations of pharmaceutical companies in a global health emergency?
In: The Lancet, Jg. 398 (2021-09-11), Heft 10304, S. 1015-1020
academicJournal
Zugriff:
Titel: |
What are the obligations of pharmaceutical companies in a global health emergency?
|
---|---|
Autor/in / Beteiligte Person: | Emanuel, Ezekiel J ; Buchanan, Allen ; Chan, Shuk Ying ; Fabre, Cécile ; Halliday, Daniel ; Heath, Joseph ; Herzog, Lisa ; Leland, R J ; McCoy, Matthew S ; Norheim, Ole F ; Saenz, Carla ; Schaefer, G Owen ; Tan, Kok-Chor ; Wellman, Christopher Heath ; Wolff, Jonathan ; Persad, Govind |
Link: | |
Zeitschrift: | The Lancet, Jg. 398 (2021-09-11), Heft 10304, S. 1015-1020 |
Veröffentlichung: | 2021 |
Medientyp: | academicJournal |
ISSN: | 0140-6736 (electronic) |
DOI: | 10.1016/S0140-6736(21)01378-7 |
Sonstiges: |
|